Timothée Proix1, Wilson Truccolo2, Marc G Leguia3, Thomas K Tcheng4, David King-Stephens5, Vikram R Rao6, Maxime O Baud7. 1. Department of Basic Neurosciences, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Neuroscience, Carney Institute for Brain Science, Brown University, Providence, RI, USA. 2. Department of Neuroscience, Carney Institute for Brain Science, Brown University, Providence, RI, USA. 3. Sleep-Wake-Epilepsy Center, NeuroTec and Center for Experimental Neurology, Department of Neurology, Inselspital Bern, University Hospital, University of Bern, Bern, Switzerland. 4. NeuroPace, Mountain View, CA, USA. 5. California Pacific Medical Center, San Francisco, CA, USA. 6. Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, CA, USA. 7. Sleep-Wake-Epilepsy Center, NeuroTec and Center for Experimental Neurology, Department of Neurology, Inselspital Bern, University Hospital, University of Bern, Bern, Switzerland; Wyss Center for Bio and Neuroengineering, Geneva, Switzerland. Electronic address: maxime.baud.neuro@gmail.com.
Abstract
BACKGROUND: People with epilepsy are burdened with the apparent unpredictability of seizures. In the past decade, converging evidence from studies using chronic EEG (cEEG) revealed that epileptic brain activity shows robust cycles, operating over hours (circadian) and days (multidien). We hypothesised that these cycles can be leveraged to estimate future seizure probability, and we tested the feasibility of forecasting seizures days in advance. METHODS: We did a feasibility study in distinct development and validation cohorts, involving retrospective analysis of cEEG data recorded with an implanted device in adults (age ≥18 years) with drug-resistant focal epilepsy followed at 35 centres across the USA between Jan 19, 2004, and May 18, 2018. Patients were required to have had 20 or more electrographic seizures (development cohort) or self-reported seizures (validation cohort). In all patients, the device recorded interictal epileptiform activity (IEA; ≥6 months of continuous hourly data), the fluctuations in which helped estimate varying seizure risk. Point process statistical models trained on initial portions of each patient's cEEG data (both cohorts) generated forecasts of seizure probability that were tested on subsequent unseen seizure data and evaluated against surrogate time-series. The primary outcome was the percentage of patients with forecasts showing improvement over chance (IoC). FINDINGS: We screened 72 and 256 patients, and included 18 and 157 patients in the development and validation cohorts, respectively. Models incorporating information about multidien IEA cycles alone generated daily seizure forecasts for the next calendar day with IoC in 15 (83%) patients in the development cohort and 103 (66%) patients in the validation cohort. The forecasting horizon could be extended up to 3 days while maintaining IoC in two (11%) of 18 patients and 61 (39%) of 157 patients. Forecasts with a shorter horizon of 1 h, possible only for electrographic seizures in the development cohort, showed IoC in all 18 (100%) patients. INTERPRETATION: This study shows that seizure probability can be forecasted days in advance by leveraging multidien IEA cycles recorded with an implanted device. This study will serve as a basis for prospective clinical trials to establish how people with epilepsy might benefit from seizure forecasting over long horizons. FUNDING: None. VIDEO ABSTRACT.
BACKGROUND:People with epilepsy are burdened with the apparent unpredictability of seizures. In the past decade, converging evidence from studies using chronic EEG (cEEG) revealed that epileptic brain activity shows robust cycles, operating over hours (circadian) and days (multidien). We hypothesised that these cycles can be leveraged to estimate future seizure probability, and we tested the feasibility of forecasting seizures days in advance. METHODS: We did a feasibility study in distinct development and validation cohorts, involving retrospective analysis of cEEG data recorded with an implanted device in adults (age ≥18 years) with drug-resistant focal epilepsy followed at 35 centres across the USA between Jan 19, 2004, and May 18, 2018. Patients were required to have had 20 or more electrographic seizures (development cohort) or self-reported seizures (validation cohort). In all patients, the device recorded interictal epileptiform activity (IEA; ≥6 months of continuous hourly data), the fluctuations in which helped estimate varying seizure risk. Point process statistical models trained on initial portions of each patient's cEEG data (both cohorts) generated forecasts of seizure probability that were tested on subsequent unseen seizure data and evaluated against surrogate time-series. The primary outcome was the percentage of patients with forecasts showing improvement over chance (IoC). FINDINGS: We screened 72 and 256 patients, and included 18 and 157 patients in the development and validation cohorts, respectively. Models incorporating information about multidien IEA cycles alone generated daily seizure forecasts for the next calendar day with IoC in 15 (83%) patients in the development cohort and 103 (66%) patients in the validation cohort. The forecasting horizon could be extended up to 3 days while maintaining IoC in two (11%) of 18 patients and 61 (39%) of 157 patients. Forecasts with a shorter horizon of 1 h, possible only for electrographic seizures in the development cohort, showed IoC in all 18 (100%) patients. INTERPRETATION: This study shows that seizure probability can be forecasted days in advance by leveraging multidien IEA cycles recorded with an implanted device. This study will serve as a basis for prospective clinical trials to establish how people with epilepsy might benefit from seizure forecasting over long horizons. FUNDING: None. VIDEO ABSTRACT.
Authors: Sarah A Janse; Sonya B Dumanis; Tanya Huwig; Sarah Hyman; Brandy E Fureman; John F P Bridges Journal: Epilepsy Behav Date: 2019-05-29 Impact factor: 2.937
Authors: Florian Mormann; Thomas Kreuz; Christoph Rieke; Ralph G Andrzejak; Alexander Kraskov; Peter David; Christian E Elger; Klaus Lehnertz Journal: Clin Neurophysiol Date: 2005-01-06 Impact factor: 3.708
Authors: Levin Kuhlmann; Klaus Lehnertz; Mark P Richardson; Björn Schelter; Hitten P Zaveri Journal: Nat Rev Neurol Date: 2018-10 Impact factor: 42.937
Authors: Philippa J Karoly; Mark J Cook; Matias Maturana; Ewan S Nurse; Daniel Payne; Benjamin H Brinkmann; David B Grayden; Sonya B Dumanis; Mark P Richardson; Greg A Worrell; Andreas Schulze-Bonhage; Levin Kuhlmann; Dean R Freestone Journal: Epilepsia Date: 2020-03-27 Impact factor: 5.864
Authors: Levin Kuhlmann; Philippa Karoly; Dean R Freestone; Benjamin H Brinkmann; Andriy Temko; Alexandre Barachant; Feng Li; Gilberto Titericz; Brian W Lang; Daniel Lavery; Kelly Roman; Derek Broadhead; Scott Dobson; Gareth Jones; Qingnan Tang; Irina Ivanenko; Oleg Panichev; Timothée Proix; Michal Náhlík; Daniel B Grunberg; Chip Reuben; Gregory Worrell; Brian Litt; David T J Liley; David B Grayden; Mark J Cook Journal: Brain Date: 2018-09-01 Impact factor: 13.501
Authors: C Alvarado-Rojas; M Valderrama; A Fouad-Ahmed; H Feldwisch-Drentrup; M Ihle; C A Teixeira; F Sales; A Schulze-Bonhage; C Adam; A Dourado; S Charpier; V Navarro; M Le Van Quyen Journal: Sci Rep Date: 2014-04-01 Impact factor: 4.379
Authors: Matias I Maturana; Christian Meisel; Katrina Dell; Philippa J Karoly; Wendyl D'Souza; David B Grayden; Anthony N Burkitt; Premysl Jiruska; Jan Kudlacek; Jaroslav Hlinka; Mark J Cook; Levin Kuhlmann; Dean R Freestone Journal: Nat Commun Date: 2020-05-01 Impact factor: 14.919
Authors: Pedro F Viana; Tal Pal Attia; Mona Nasseri; Jonas Duun-Henriksen; Andrea Biondi; Joel S Winston; Isabel Pavão Martins; Ewan S Nurse; Matthias Dümpelmann; Andreas Schulze-Bonhage; Dean R Freestone; Troels W Kjaer; Mark P Richardson; Benjamin H Brinkmann Journal: Epilepsia Date: 2022-04-08 Impact factor: 6.740
Authors: Marc G Leguia; Ralph G Andrzejak; Christian Rummel; Joline M Fan; Emily A Mirro; Thomas K Tcheng; Vikram R Rao; Maxime O Baud Journal: JAMA Neurol Date: 2021-04-01 Impact factor: 18.302
Authors: Philippa J Karoly; Dean R Freestone; Dominique Eden; Rachel E Stirling; Lyra Li; Pedro F Vianna; Matias I Maturana; Wendyl J D'Souza; Mark J Cook; Mark P Richardson; Benjamin H Brinkmann; Ewan S Nurse Journal: Front Neurol Date: 2021-08-04 Impact factor: 4.003
Authors: Sharon Chiang; Robert Moss; Angela P Black; Michele Jackson; Chuck Moss; Jonathan Bidwell; Christian Meisel; Tobias Loddenkemper Journal: JAMIA Open Date: 2021-03-01
Authors: Sharon Chiang; Ankit N Khambhati; Emily T Wang; Marina Vannucci; Edward F Chang; Vikram R Rao Journal: Brain Stimul Date: 2021-02-06 Impact factor: 8.955
Authors: Philippa J Karoly; Vikram R Rao; Maxime O Baud; Nicholas M Gregg; Gregory A Worrell; Christophe Bernard; Mark J Cook Journal: Nat Rev Neurol Date: 2021-03-15 Impact factor: 42.937
Authors: Benjamin H Brinkmann; Philippa J Karoly; Ewan S Nurse; Sonya B Dumanis; Mona Nasseri; Pedro F Viana; Andreas Schulze-Bonhage; Dean R Freestone; Greg Worrell; Mark P Richardson; Mark J Cook Journal: Front Neurol Date: 2021-07-13 Impact factor: 4.003
Authors: Sharon Chiang; Rosalind W Picard; Winston Chiong; Robert Moss; Gregory A Worrell; Vikram R Rao; Daniel M Goldenholz Journal: Neurology Date: 2021-07-27 Impact factor: 11.800